{"id":"https://openalex.org/W1585803830","doi":"https://doi.org/10.1002/9781118589199.ch4","title":"Management of T\u2010Cell Acute Lymphoblastic Leukemia","display_name":"Management of T\u2010Cell Acute Lymphoblastic Leukemia","publication_year":2014,"publication_date":"2014-06-20","ids":{"openalex":"https://openalex.org/W1585803830","doi":"https://doi.org/10.1002/9781118589199.ch4","mag":"1585803830"},"language":"en","primary_location":{"id":"doi:10.1002/9781118589199.ch4","doi":"https://doi.org/10.1002/9781118589199.ch4","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9781118589199.ch4","pdf_url":null,"source":{"id":"https://openalex.org/S4306464293","display_name":"Wiley eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Consult: Expertise for Clinical Practice","raw_type":"other"},"volume":{"id":"https://openalex.org/W2490175513","display_name":"Cancer Consult: Expertise for Clinical Practice"},"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5082924494"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"29","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":1.0},{"id":"https://openalex.org/keywords/early-t-cell-precursor-all","display_name":"early T-cell precursor ALL","score":0.9769999980926514},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/l-asparaginase","display_name":"L-asparaginase","score":0.9829999804496765},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.902999997138977},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.9070000052452087},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.968999981880188},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8579999804496765},{"id":"https://openalex.org/keywords/hyper-cvad","display_name":"hyper-CVAD","score":0.9359999895095825},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pediatric-all","display_name":"pediatric ALL","score":0.4860000014305115},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7139999866485596},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9819999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7322478890419006},{"id":"https://openalex.org/C2781021840","wikidata":"https://www.wikidata.org/wiki/Q411659","display_name":"Daunorubicin","level":3,"score":0.7289363741874695},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.5628845691680908},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5351681709289551},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5257433652877808},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5141058564186096},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4578823149204254},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.4518149495124817},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.4200303256511688},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4049876630306244},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3914250135421753},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33569595217704773},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10899671912193298},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/9781118589199.ch4","doi":"https://doi.org/10.1002/9781118589199.ch4","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9781118589199.ch4","pdf_url":null,"source":{"id":"https://openalex.org/S4306464293","display_name":"Wiley eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Consult: Expertise for Clinical Practice","raw_type":"other"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W57971082","https://openalex.org/W1862517694","https://openalex.org/W2010729137","https://openalex.org/W2060605982","https://openalex.org/W2061585822"],"related_works":["https://openalex.org/W2990689630","https://openalex.org/W2580322451","https://openalex.org/W2953350029","https://openalex.org/W4394018281","https://openalex.org/W4289963250","https://openalex.org/W2584776346","https://openalex.org/W1559637642","https://openalex.org/W2555070547","https://openalex.org/W4311679972","https://openalex.org/W2577173749"],"abstract_inverted_index":{"This":[0],"chapter":[1],"illustrates":[2],"through":[3],"case":[4],"studies":[5],"how":[6],"T-cell":[7,25,36],"acute":[8],"lymphoblastic":[9],"leukemia":[10],"(T-ALL)":[11],"is":[12,47,103,156],"managed.":[13],"T-ALL":[14,45],"has":[15,64,81],"three":[16],"immunologic":[17],"subtypes":[18],"that":[19],"correspond":[20],"to":[21,48,75,173],"different":[22],"stages":[23],"of":[24,85,95,132],"development:":[26],"thymic":[27],"(or":[28],"cortical)":[29],"T-ALL,":[30,33],"mature":[31],"(medullary)":[32],"and":[34,57,89,97,114,117,134,167],"early":[35],"precursor":[37],"(ETP)":[38],"ALL.":[39],"The":[40,153],"most":[41,53],"appropriate":[42],"therapy":[43],"for":[44,123,159],"patients":[46,106,128],"intensify":[49],"the":[50,120,130],"induction":[51],"therapy;":[52],"regimens":[54,147],"add":[55],"asparaginase":[56],"an":[58],"anthracycline":[59],"(daunorubicin":[60],"or":[61],"doxorubicin),":[62],"which":[63],"resulted":[65],"in":[66,105],"improved":[67],"complete":[68],"remission":[69],"(CR)":[70],"rates":[71,94],"ranging":[72],"from":[73],"72%":[74],"92%.":[76],"An":[77],"alternative":[78],"regimen,":[79],"hyper-CVAD,":[80],"a":[82],"CR":[83],"rate":[84],"91%":[86],"with":[87,107,142,161],"3-":[88],"5-year":[90,154],"disease-free":[91],"survival":[92],"(DFS)":[93],"50%":[96],"38%,":[98],"respectively.":[99],"Allogeneic":[100],"SCT":[101],"(allo-SCT)":[102],"used":[104],"well-known":[108],"risk":[109],"factors":[110],"such":[111],"as":[112],"t(9;22)":[113],"t(4;11)":[115],"cytogenetics,":[116],"may":[118,137],"represent":[119],"optimal":[121],"approach":[122],"curing":[124],"these":[125],"patients.":[126],"Younger":[127],"between":[129],"ages":[131],"16":[133],"21":[135],"years":[136],"fare":[138],"better":[139],"when":[140],"treated":[141],"intensive":[143],"pediatric":[144],"ALL":[145],"treatment":[146],"rather":[148],"than":[149],"conventional":[150],"adult":[151],"regimens.":[152],"DFS":[155],"approximately":[157],"40%":[158],"adults":[160],"ALL;":[162],"many":[163],"will":[164],"eventually":[165],"relapse":[166],"subsequently":[168],"be":[169],"much":[170],"less":[171],"responsive":[172],"salvage":[174],"therapy.":[175]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}